Dose Finding Study to Evaluate the Safety of BSB-2002 in Relapsed or Refractory Acute Myeloid Leukemia (AML) Patients With NPM1 Mutation
for AML - Acute Myeloid Leukemia
1 location in St Louis
Sponsor: BlueSphere Bio, Inc
Sex: All·Age: 18+
Code: NCT07566585·Phase 1·Recruiting